Luis Gerardo Rodriguez

Grupo de investigación

Mieloma, amiloidosis, macroglobulinemia y otras gammapatías Accredited researcher (R3A)

lgrodriguez@clinic.cat 0000-0001-5694-0921

Síguelo/a en:

El perfil Researchgate de Luis Gerardo . Este enlace se abre en una nueva pestaña.

Publicaciones destacadas

Complement as the enabler of carfilzomib-induced thrombotic microangiopathy

Autores:
Blasco, M; Quintana, LF; Poch, E; Guillen, E; Campistol, JM;

(...)

Castro, P; Fernandez, S; Carreras, E; Palomo, M; Diaz-Ricart, M.

Referencia: British Journal Of Haematology 2021.
Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma

Autores:
Lozano, Ester; Mena, Mari-Pau; Diaz, Tania; Martin-Antonio, Beatriz; Leon, Sheila;

(...)

Teresa Cibeira, Maria; Blade, Joan; Prat, Aleix; Rosinol, Laura; Fernandez de Larrea, Carlos.

Referencia: Clinical Cancer Research 2020.
CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions

Autores:
Gerardo Rodriguez-Lobato, Luis; Ganzetti, Maya; Fernandez de Larrea, Carlos; Hudecek, Michael; Einsele, Hermann;

Danhof, Sophia.

Referencia: Frontiers In Oncology 2020.
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis

Autores:
Gutiérrez-García, G; Garrote, M; Rovira, M; Suárez-Lledó, M; Rodríguez-Lobato, LG;

(...)

Cid, J; Poch, E; Pereira, A; Quintana, LF; Carreras, E.

Referencia: Bone Marrow Transplantation 2020.
Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients

Autores:
Rodríguez-Lobato, LG; Martínez-Roca, A; Moreno, DF; Gutiérrez-García, G; Suarez-Lledó, M;

(...)

Lozano, M; Cardozo, C; Puerta-Alcalde, P; Garcia-Vidal, C; Marín, P.

Referencia: Leukemia & Lymphoma 2020.
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe

Autores:
Gutiérrez-García, G; Rovira, M; Arab, N; Gallego, C; Sánchez, J;

(...)

Urbano-Ispizua, A; Fernández-Avilés, F; Lozano, M; Cid, J; Carcelero, E.

Referencia: Bone Marrow Transplantation 2020.
Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.

Autores:
Gonzalo Gutiérrez García; María Teresa Cibeira; Montserrat Rovira; Carlos Fernández de Larrea; Natalia Tovar;

(...)

Álvaro Urbano Ispizua; Jordi Esteve; Enric Carreras; Francesc Fernández Avilés; Joan Bladé.

Referencia: Bone Marrow Transplantation 2019.
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.

Autores:
Lozano, Ester; Diaz, Tania; Mena, Mari-Pau; Sune, Guillermo; Calvo, Xavier;

(...)

Isola, Ignacio; Rodriguez-Lobato, Luis-Gerardo; Martin-Antonio, Beatriz; Blade, Joan; Fernandez De larrea, Carlos.

Referencia: Journal Of Immunology 2018.
Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome.

Autores:
Tovar N; Rodríguez-Lobato LG; Cibeira MT; Magnano L; Isola I;

Rosiñol L; Bladé J; Fernández de Larrea C .

Referencia: Amyloid-Journal Of Protein Folding Disorders 2018.
Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis

Autores:
Rodríguez-Lobato L; Fernández de Larrea C; Cibeira M; Tovar N; Isola I;

(...)

Rosiñol L; Díaz T; Lozano E; Yagüe J; Bladé J.

Referencia: Amyloid-Journal Of Protein Folding Disorders 2017.

Proyectos destacados

Ensayo clínico fase II sobre el uso de un CART humanizado dirigido contra BCMA (ARI0002h) en pacientes con mieloma múltiple recaído/refractario a inhibidores del proteasoma, inmunomoduladores y anticuerpos anti-CD38

Financiador: Clínica Universitaria de Navarra; Complejo Hospitalario de Salamanca; Hospital Clínic de Barcelona; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Participante)

Duración: 01/01/2019
Biomedicine international training research programme for excellent clinician-scientists "BITRECS"

Investigador/a principal: Luis Gerardo Rodríguez Lobato

Financiador: Institut d'investigació Biomèdiques August Pi i Sunyer (Sede o evento); La Caixa Foundation; Comisión Europea ; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Participante); Biomedicine international training research programme for excellent clinician-scientists (BITRECS) (Programa financiador competitivo)

Duración: 01/09/2019 - 01/08/2022
Improving CAR T cell immunotherapy through immune checkpoint inhibition to achieve a sustained response in patients with multiple myeloma.

Investigador/a principal: David Fernando Moreno Fajardo

Financiador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)

Duración: 01/01/2019 - 01/01/2020

Luis Gerardo Rodriguez

Grupo de investigación

Publicaciones destacadas

Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.

Proyectos destacados

Ensayo clínico fase II sobre el uso de un CART humanizado dirigido contra BCMA (ARI0002h) en pacientes con mieloma múltiple recaído/refractario a inhibidores del proteasoma, inmunomoduladores y anticuerpos anti-CD38

Biomedicine international training research programme for excellent clinician-scientists "BITRECS"

Improving CAR T cell immunotherapy through immune checkpoint inhibition to achieve a sustained response in patients with multiple myeloma.

Suscríbete a la Newsletter del Clínic